Transmembrane domain of Bcl-2 is required for inhibition of ceramide synthesis, but not cytochrome c release in the pathway of inostamycin-induced apoptosis

Experimental Cell Research

Volumn 286, Issue 1, 2003, Pages 57-66

  Kawatani, Makoto ^a   Uchi, Madoka ^a   Simizu, Siro ^b   Osada, Hiroyuki ^b   Imoto, Masaya ^a  

^a KEIO UNIVERSITY   (Japan)

^b RIKEN   (Japan)

Author keywords

Apoptosis; Bcl 2; Ceramide; Inostamycin

Indexed keywords

CERAMIDE; CYTOCHROME C; INOSTAMYCIN; MEMBRANE PROTEIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CHROMOSOME DELETION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

EID: 0037447896     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00098-3     Document Type: Article

References (51)

1. Perry G., Nunomura A., Lucassen P., Lassmann H., Smith M.A. Apoptosis and alzheimer's disease. Science. 282:1998;1265.
2. Nicholson D.W., Thornberry N.A. Caspases killer proteases . Trends Biochem. Sci. 22:1997;299-306.
3. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
4. Oltvai Z.N., Korsmeyer S.J. Checkpoints of dueling dimmers foil death wishes. Cell. 79:1994;189-192.
5. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
6. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
7. Fernandez-Sarabia M.J., Bischoff J.R. Bcl-2 associates with the ras-related protein R-ras p23. Nature. 366:1993;274-275.
8. Wang H.G., Rapp U.R., Reed J.C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:1996;629-638.
9. Grimm S., Bauer M.K., Baeuerle P.A., Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell Biol. 134:1996;13-23.
10. Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signaling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 386:1997;728-731.
11. Iwahashi H., Eguchi Y., Yasuhara N., Hanafusa T., Matsuzawa Y., Tsujimoto Y. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature. 390:1997;413-417.
12. Yoshimura S., Banno Y., Nakashima S., Takenaka K., Sakai H., Nishimura Y., Sakai N., Shimizu S., Eguchi Y., Tsujimoto Y., Nozawa Y. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. J. Biol. Chem. 273:1998;6921-6927.
13. Tepper A.D., de Vries E., van Blitterswijk W.J., Borst J. Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis. J. Clin. Invest. 103:1999;971-978.
14. Sawada M., Nakashima S., Banno Y., Yamakawa H., Takenaka K., Shinoda J., Nishimura Y., Sakai N., Nozawa Y. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Oncogene. 19:2000;3508-3520.
15. Adams J.M., Cory S. The Bcl-2 family arbiters of cell survival . Science. 281:1998;1322-1325.
16. Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis apoptosomes or mitochondria? Genes Cells. 3:1998;697-707.
17. Yin X.M., Oltvai Z.N., Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:1994;321-323.
18. L-Bak peptide complex recognition between regulators of apoptosis . Science. 275:1997;983-986.
19. Borner C., Martinou I., Mattmann C., Irmler M., Schaerer E., Martinou J.C., Tschopp J. The protein bcl-2α does not require membrane attachment, but two conserved domains to suppress apoptosis. J. Cell Biol. 126:1994;1059-1068.
20. Hanada M., Aime-Sempe C., Sato T., Reed J.C. Structure-function analysis of Bcl-2 protein identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax . J. Biol. Chem. 270:1995;11962-11969.
21. Hunter J.J., Bond B.L., Parslow T.G. Functional dissection of the human Bcl2 protein sequence requirements for inhibition of apoptosis . Mol. Cell. Biol. 16:1996;877-883.
22. Lee L.C., Hunter J.J., Mujeeb A., Turck C., Parslow T.G. Evidence for α-helical conformation of an essential N-terminal region in the human Bcl2 protein. J. Biol. Chem. 271:1996;23284-23288.
23. Huang D.C.S., Adams J.M., Cory S. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J. 17:1998;1029-1039.
24. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., Reed J.C. Investigation of the subcellular distribution of the bcl-2 oncoprotein residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes . Cancer Res. 53:1993;4701-4714.
25. Akao Y., Otsuki Y., Kataoka S., Ito Y., Tsujimoto Y. Multiple subcellular localization of bcl-2 detection in nuclear outer membrane, endoplasmic membrane, and mitochondrial membranes . Cancer Res. 54:1994;2468-2471.
26. Chen-Levy Z., Nourse J., Cleary M.L. The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14; 18) translocation. Mol. Cell. Biol. 2:1989;701-710.
27. L, an inhibitor of programmed cell death. Nature. 381:1996;335-341.
28. Imoto M., Umezawa K., Takahashi Y., Naganawa H., Iitaka Y., Nakamura H., Koizumi Y., Sasaki Y., Hamada M., Sawa T., Takeuchi T. Isolation and structure determination of inostamycin, a novel inhibitor of phosphatidylinositol turnover. J. Nat. Prod. 53:1990;825-829.
29. Deguchi A., Imoto M., Umezawa K. Inhibition of G1 cyclin expression in normal rat kidney cells by inostamycin, a phosphatidylinositol synthesis inhibitor. J. Biochem. (Tokyo). 120:1996;1118-1122.
30. Imoto M., Tanabe K., Simizu S., Tashiro E., Takada M., Umezawa K. Inhibition of Cyclin D1 expression and induction of apoptosis by inostamycin in small cell lung carcinoma cells. Jpn. J. Cancer Res. 89:1998;315-322.
31. Kawatani M., Simizu S., Osada H., Takada M., Arber N., Imoto M. Involvement of protein kinase C-regulated ceramide generation in inostamycin-induced apoptosis. Exp. Cell Res. 259:2000;389-397.
32. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2 release of cytochrome c from mitochondria blocked . Science. 275:1997;1129-1132.
33. van Veldhoven P.P., Bishop W.R., Yurivich D.A., Bell R.M. Ceramide quantitation evaluation of a mixed micellar assay using E. coli diacylglycerol kinase . Biochem. Mol. Biol. Int. 36:1995;21-30.
34. Masamune A., Igarashi Y., Hakomori S. Regulatory role of ceramide in interleukin (IL)-1β-induced E-selectin expression in human umbilical vein endothelial cells. J. Biol. Chem. 271:1996;9368-9375.
35. Zhang J., Alter N., Reed J.C., Borner C., Obeid L.M., Hannun Y.A. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl. Acad. Sci. USA. 93:1996;5325-5328.
36. Allouche M., Bettaieb A., Vindis C., Rousse A., Grignon C., Laurent G. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells. Oncogene. 14:1997;1837-1845.
37. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:1997;614-620.
38. Nguyen M., Millar D.G., Yong V.W., Korsmeyer S.J., Shore G.C. Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J. Biol. Chem. 268:1993;25265-25268.
39. Nguyen M., Branton P.E., Walton P.A., Oltvai Z.N., Korsmeyer S.J., Shore G.C. Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J. Biol. Chem. 269:1994;16521-16524.
40. Mandon E.C., Ehses I., Rother J., van Echten G., Sandhoffg K. Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver. J. Biol. Chem. 267:1992;11144-11148.
41. Perry D.K., Carton J., Shah A.K., Meredith F., Uhlinger D.J., Hannun Y.A. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem. 275:2000;9078-9084.
42. Choi W.S., Yoon S.Y., Chang I.I., Choi E.J., Rhim H., Jin B.K., Oh T.H., Krajewski S., Reed J.C., Oh Y.J. Correlation between structure of Bcl-2 and its inhibitory function of JNK and caspase activity in dopaminergic neuronal apoptosis. J. Neurochem. 74:2000;1621-1626.
43. Wang H.G., Takayama S., Rapp U.R., Reed J.C. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA. 93:1996;7063-7068.
44. Wang K., Yin X.M., Chao D.T., Milliman C.L., Korsmeyer S.J. BID a novel BH3 domain-only death agonist . Genes Dev. 10:1996;2859-2869.
45. L and Bcl-2. EMBO J. 16:1997;968-977.
46. Fang G., Chang B.S., Kim C.N., Perkins C., Thompson C.B., Bhalla K.N. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res. 58:1998;3202-3208.
47. Wang S., Wang Z., Boise L., Dent P., Grant S. Loss of the Bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis. Biochem. Biophys. Res. Commun. 259:1999;67-72.
48. Cheng E.H.-Y., Kirsch D.G., Clem R.J., Ravi R., Kastan M.B., Bedi A., Ueno K., Hardwick J.M. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 278:1997;1996-1998.
49. L. Nature. 379:1996;554-556.
50. L. Mol. Cell. Biol. 17:1997;7040-7046.
51. Oh Y.J., Uhland-Smith A., Kim J.E., O'Malley K.L. Regions outside of the Bcl-2 homology domains, BH1 and BH2 protect a dopaminergic neuronal cell line from staurosporine-induced cell death. Mol. Brain Res. 51:1997;133-142.